TDOC stock gains ahead of October 28 results

Published on 10/05/2026 at 18:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TDOC stock trades at USD 5.63 on October 5, 2026, up 2.08 percent intraday. Q2 revenue fell 4 percent, while adjusted EPS beat consensus by USD 0.04.

TDOC, US87918A1051, Illustration mit AI erstellt.

TDOC stock was trading at USD 5.63 on the NYSE on October 5, 2026, up 2.08 percent at 12:49 p.m. ET. Teladoc Health is scheduled to report third-quarter 2026 results on October 28, 2026, after the market closes, according to MarketBeat.

Revenue pressure defines Q2

Teladoc reported second-quarter 2026 revenue of USD 606.93 million, down 4 percent from the same quarter a year earlier. The adjusted loss was USD 0.21 per share, beating the USD 0.25 consensus loss by USD 0.04, according to MarketBeat.

The earnings mix shows why the October report matters. Integrated Care revenue reached USD 394.3 million, up 1 percent year over year, while BetterHelp revenue declined 11.6 percent to USD 212.6 million in Q2 2026, according to The Globe and Mail.

Insurance transition remains central

Management is shifting BetterHelp toward insurance-covered services as consumer demand moves away from cash pay. The company reported USD 22 million of BetterHelp insurance revenue in Q2 2026, up USD 9 million sequentially, while chronic care enrollment rose 14 percent year over year to 1.27 million, according to The Globe and Mail.

For full-year 2026, Teladoc guided to revenue of USD 2.36 billion to USD 2.45 billion and adjusted EBITDA of USD 271 million to USD 303 million. BetterHelp revenue guidance was USD 770 million to USD 830 million, making execution in the insurance rollout the key operating test for the next report.

Analysts see limited upside

The consensus rating is Hold among 16 research firms, including 10 Holds, five Buys and one Sell. The average 12-month price target is USD 7.54, compared with the USD 5.63 NYSE price on October 5, 2026, according to MarketBeat. The target lies 33.9 percent above the price, but the consensus also reflects Teladoc's continuing losses and the 4 percent Q2 revenue decline.

TDOC stock trades below its yearly high

TDOC stock was trading at USD 5.63 on the NYSE on October 5, 2026, with a session range of USD 5.49 to USD 5.66. Its 52-week range was USD 4.40 to USD 9.89, and market capitalization stood at USD 1.0 billion.